N/A N=159 Development of Eating Disorders Symptoms Among Children
Eating Disorders Symptoms
Primary: Number of Participants With >20 on the 26 Children Eating Attitudes Test — 26; 4 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=180 Efficacy Trial of a Dissonance Based Eating Disorder Program
Eating Disorder
Primary: Rosenberg Self-Esteem Scale (RSE). — 22.71; 22.50; 22.62 units on a scale
N/A N=99 Fear, Gastrointestinal Distress, and Interoception: Physiological and Psychological Mechanisms in Eating Disorders
Feeding and Eating Disorders
Primary: Subjective Rating of Fear — -36.9444; -23.9219; -47.3611; 85.6250 units on scale*minutes — p=.879
N/A N=100 Self-Control in Bulimia Nervosa
Bulimia Nervosa
Primary: Brain Activation Associated With P(Stop) — 0.02; 0.11; 0.04; 0.05 BOLD Signal
Phase 1 N=148 Leveraging Social Media to Identify and Connect Teens With Eating Disorders to a Mobile Guided Self-Help Mobile Intervention
Eating Disorders
Primary: Eating Disorder Psychopathology — 3.75; 3.93; 3.71; 3.50 EDE-Q Global score — p=0.90
Phase 2 N=10 Neurobiology of Bulimia Nervosa
Bulimia Nervosa
Primary: Change in Binge Eating Sum Score — -0.60; 0.89 score on a scale
Early Phase 1 N=13 Dopamine Receptor Contributions to Prediction Error and Reversal Learning in Anorexia Nervosa
Anorexia Nervosa
Primary: Measurement of Brain Activation (Measured in Percent Signal Change) During a Prediction Error Taste Reward Task Using Functional Magnetic Resonance Imaging (fMRI)…
N/A N=50 Cognitive Behavioral Therapy for Adolescent Binge Eating and Loss of Control Eating
Binge Eating · Eating Disorders in Adolescence · Overweight and Obesity
Primary: Binge (Loss-of-control) Eating Episode Frequency — 1.52; 6.05 episodes of behavior — p=.01
N/A N=55 Eating Disorder Prevention Program for Women With T1D
Eating Disorders · Type 1 Diabetes
Primary: Percentage of Time With Blood Sugar in Range as a Measure of Glycemic Control — 0.61; 0.63 percentage of time
Phase 4 N=88 Monoamine Contributions to Neurocircuitry in Eating Disorders
Eating Disorder
Primary: 5-HT Transporter Binding as Measured During the PET Scan — 1.68; 1.54; 1.46; 1.60 binding potential (BPND) — p=> 0.05
N/A N=71 An fMRI Study of Self-regulation in Adolescents With Bulimia Nervosa
Eating Disorders
Primary: Magnetic Resonance Imaging Scans — 2.98; 2.96 mm — p=.03
N/A N=177 Shifting Perspectives: Enhancing Outcomes in Anorexia Nervosa With CRT
Anorexia Nervosa
Primary: Change in Cognitive Flexibility - Condition 4 Trail Making Test of DKEFS — 11.89; 10.94; 11.47; 11.14 score on a scale — p=.507
N/A N=40 Escitalopram Treatment of Night Eating Syndrome
Night Eating Syndrome
Primary: Night Eating Questionnaire — -13.0; -10.6 units on a scale
N/A N=59 Comparing the Effectiveness of Two Therapies to Treat Signs of Anorexia Nervosa in Adolescents
Eating Disorders
Primary: Body Mass Index (BMI) Z-score — -0.72; -0.02 z-score
N/A N=117 Multi-Family Group Therapy for Adult Eating Disorders
Eating Disorders
Primary: Dropout — 17; 18 participants
N/A N=300 Psychopathology, Disordered Eating, and Impulsivity as Predictors of Outcomes of Bariatric Surgery
Obesity
Primary: Percent Weight Change — 23.0; 26.2; 23.3 percent weight change
N/A N=61 Eating Behaviour in Crohn's Disease
Crohn's Disease
Primary: Dietary Recalls (Calorific Intake) — 1900.9; 2054.3 kcal
N/A N=24 MUMMIBODIES. Eating Disorders, Pregnancy and Post Partum Period.
Mental Health Disorder · Eating Disorders · Pregnancy Related
Primary: Number of Participants With Each Type of Personal Features Associated With Worsening or Relapse of Eating Disorder Symptoms During Pregnancy (Time Point 1) — 5; 3; 3; 4…
N/A N=15 Trial of Quetiapine in Anorexia Nervosa
Anorexia Nervosa
Primary: Hours Occupied by Preoccupations and Rituals Assessed by Yale-Brown-Cornell Eating Disorder Scale (YBC-EDS) — NA; NA; NA; NA Hours — p=.15
Phase 4 N=41 A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa
Anorexia Nervosa
Primary: Change in Eating Disorder Inventory-2 Drive for Thinness Subscale (DT) — 1.36; 3.93 units on a scale
N/A N=5 An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder
Bulimia Nervosa · Body Dysmorphic Disorder
Primary: Number of Binge Eating and Self-induced Vomiting Episodes — 20.67; 31.33; 21.67; 36.67 number of episodes
N/A N=152 Olanzapine Versus Placebo for Outpatients With Anorexia Nervosa
Anorexia Nervosa
Primary: Rate of Weight Change — 0.095; 0.260 kg/m^2 per month
N/A N=20 Binge Eating Syndrome Treatment for Older Women (BESTOW)
Binge Eating
Primary: Feasibility - Usage Rating Profile - Intervention — 5.44; 5.53 score on a scale
N/A N=205 Treatment Uptake Chatbot for Eating Disorders
Eating Disorders
Primary: Rates of Treatment/Services Utilization for Eating, Shape, or Weight Concerns Among All Participants Randomized to the Intervention Following Online Eating Disorder…
Phase 2 N=90 Hormonal Factors in the Treatment of Anorexia Nervosa
Anorexia Nervosa · Eating Disorder · Anxiety
Primary: Change From Baseline in Weight — 0.1; 1.5 kilograms
N/A N=33 Young Adult Eating Habits
Eating Behavior · Eating Habit
Primary: Change in Brain Response From Baseline to 2-weeks Post High UPF or 2 Weeks no UPF Diet — 0.02; 0.13 arbitrary units
N/A N=481 Efficacy of the Female Athlete Body Project (FAB)
Eating Disorders · Female Athlete Triad
Primary: Eating Disorder Examination Questionnaire (EDE-Q) — .98; 1.24; .54; .84 units on a scale
N/A N=1,881 Impact of Diet on Functional Gastrointestinal Symptoms
Gastrointestinal Disorder, Functional
Primary: Most Common Triggers for Food-related GI Symptoms (Top 5) — 881; 494; 469; 460 Participants
N/A N=68 Mobile Attention Retraining in Overweight Female Adolescents
Obesity · Overweight · Binge Eating
Primary: Changes in Food-cue Visual Probe Task Attention Bias (AB) Reaction Time — 1.85; 4.27 Change in milliseconds
N/A N=23 PET Imaging Study of Recovered Anorexics
Anorexia Nervosa
Primary: Serotonin Receptor 1A Binding Potential In Regions of Interest (ROI) Accounting for Binding Potential in a Region Without Serotonin 1A Receptors — 5.97; 5.89; 6.66; 6.91…